New patent for the drug Fresenius Kabi DILAUDID-HP – DrugPatentWatch
Annual Drug Patent Expiration for DILAUDID-HP
Dilaudid-hp is a drug marketed by Fresenius Kabi Usa and is included in one NDA. It is available from a single supplier. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has eighteen patent family members in twelve countries.
The generic ingredients in DILAUDID-HP are hydromorphone hydrochloride. One registered supplier for this compound. Additional details are available on the hydromorphone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug Fresenius Kabi DILAUDID-HP
